1. Home
  2. List
Reference Patent

Reference - List

  • 223 Hits
  • Search Condition : Filter (MeSH = Drug Synergism)
Species Resource Title
Human and Animal Cells JHOC-5(RCB2226) PI3K/mTOR Dual Inhibitor GSK458 and Arsenic Trioxide Exert Synergistic Antitumor Effects against Ovarian Clear-Cell Carcinoma.
Human and Animal Cells PK-8(RCB2700) Concurrent Inhibition of the RAS-MAPK Pathway and PIKfyve Is a Therapeutic Strategy for Pancreatic Cancer.
Human and Animal Cells Huh7(RCB1366) , Huh6(RCB1367) Dual Inhibition of CDK4/6 and XPO1 Induces Senescence With Acquired Vulnerability to CRBN-Based PROTAC Drugs.
Human and Animal Cells KG-1(RCB1166) , K562(RCB0027) The combination of venetoclax and quercetin exerts a cytotoxic effect on acute myeloid leukemia.
Human and Animal Cells MIA Paca2(RCB2094) , PANC-1(RCB2095) FOXO3a Activation by HDAC Class IIa Inhibition Induces Cell Cycle Arrest in Pancreatic Cancer Cells.
Human and Animal Cells NB-1(RCB1953) , NB9(RCB0477) , NB19(RCB0479) , CHP-134(RCB0487) Zoledronate sensitizes neuroblastoma-derived tumor-initiating cells to cytolysis mediated by human γδ T cells.
Human and Animal Cells TE-1(RCB1894) , TE-4(RCB2097) , TE-5(RCB1949) , TE-6(RCB1950) , TE-8(RCB2098) , TE-9(RCB1988) , TE-10(RCB2099) , TE-11(RCB2100) , TE-14(RCB2101) , TE-15(RCb1951) Cetuximab inhibits cisplatin-induced activation of EGFR signaling in esophageal squamous cell carcinoma.
Human and Animal Cells SQ-5(RCB0110) Additive effects of antitumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing determined by lactate-dehydrogenase-release assay.
Human and Animal Cells U251(RCB0461) Synthesis and anticancer activity of new 1-[(5 or 6-substituted 2-alkoxyquinoxalin-3-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives.
Human and Animal Cells WEHI-3(RCB0035) , Ba/F3(RCB0805) Synergistic killing effect of imatinib and simvastatin on imatinib-resistant chronic myelogenous leukemia cells.
Human and Animal Cells VMRC-RCW(RCB1963) Enhancement of IL-2-induced cytotoxicity by interferon-alpha in renal cell carcinoma.
Human and Animal Cells LM8(RCB1450) Hyperbaric oxygen as a chemotherapy adjuvant in the treatment of osteosarcoma.
Human and Animal Cells PC-12(RCB0009) Calcineurin contributes to the enhancing effect of adenosine on nerve growth factor-induced neurite outgrowth via the decreased duration of p38 mitogen-activated protein kinase phosphorylation.
Human and Animal Cells L929 Bacterial exopolysaccharide based magnetic nanoparticles: a versatile nanotool for cancer cell imaging, targeted drug delivery and synergistic effect of drug and hyperthermia mediated cancer therapy.
Human and Animal Cells KGN(RCB1154) Procaspase-Activating Compound-1 Synergizes with TRAIL to Induce Apoptosis in Established Granulosa Cell Tumor Cell Line (KGN) and Explanted Patient Granulosa Cell Tumor Cells In Vitro.
Human and Animal Cells TE-1(RCB1894) The Mechanism of the Synergistic Anticancer Effect of CDDP and EPA in the TE1 Cell Line.
Human and Animal Cells EBC-1(RCB1965) Selective beta2-adrenoceptor agonist enhances sensitivity to cisplatin in non-small cell lung cancer cell line.
Human and Animal Cells HeLa , A549 , MCF7(RCB1904) , MKN74(RCB1002) , A431 , PANC-1(RCB2095) , MIA Paca2(RCB2094) , 1B2C6(RCB0795) , 1C3D3(RCB0796) Identification of a Small-Molecule Glucose Transporter Inhibitor, Glutipyran, That Inhibits Cancer Cell Growth.
General Microbes JCM21189 , JCM3725 , JCM32818 Rosmarinic Acid and Sodium Citrate Have a Synergistic Bacteriostatic Effect against Vibrio Species by Inhibiting Iron Uptake.
Human and Animal Cells TUHR10TKB(RCB1275) , OS-RC-2(RCB0735) , RCC10RGB(RCB1151) The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma.